GNAS Is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct

American Journal of Surgical Pathology

Volumn 37, Issue 12, 2013, Pages 1862-1870

  Tsai, Jia Huei ^a   Yuan, Ray Hwang ^a   Chen, Yu Ling ^b   Liau, Jau Yu ^a   Jeng, Yung Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

GNAS; intraductal papillary neoplasm of the bile duct; KRAS; mucin

Indexed keywords

GNAS PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; BILE DUCT TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MUTATION; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, PAPILLARY; DNA MUTATIONAL ANALYSIS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84888129945     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182986bb5     Document Type: Article

References (35)

1. Bickenbach K, Galka E, Roggin KK. Molecular mechanisms of cholangiocarcinogenesis: Are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinomä Surg Oncol Clin N Am. 2009;18:215-224
2. Nakanuma Y. A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: Is the biliary tract an incomplete pancreas? Pathol Int. 2010;60:419-429
3. Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333-1343
4. Paik KY, Heo JS, Choi SH, et al. Intraductal papillary neoplasm of the bile ducts: The clinical features and surgical outcome of 25 cases. J Surg Oncol. 2008;97:508-512
5. Albores-Saavedra J, Kloppel G, Adsay NV, et al. WHO classification of tumours of the digestive system. In: Bosman FT, Carneiro F, eds. World Health Organization Classification of Tumours. 4th ed. Lyon, France: IARC; 2010:266-273
6. Ohtsuka M, Kimura F, Shimizu H, et al. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol. 2011;35:512-521
7. Shibahara H, Tamada S, Goto M, et al. Pathologic features of mucin-producing bile duct tumors: Two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2004;28:327-338
8. Kim HJ, KimMH, Lee SK, et al.Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy. 2000;32:389-393
9. Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001;34:651-658
10. Yeh TS, Tseng JH, Chen TC, et al. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology. 2005;42:657-664
11. Yang J, Wang W, Yan L. The clinicopathological features of intraductal papillary neoplasms of the bile duct in a Chinese population. Dig Liver Dis. 2012;44:251-256
12. Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:92ra66
13. Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011;1:161
14. Weinstein LS, Liu J, Sakamoto A, et al. Minireview: GNAS: Normal and abnormal functions. Endocrinology. 2004;145:5459-5464
15. Levine MA. The McCune-Albright syndrome. The whys and wherefores of abnormal signal transduction. N Engl J Med. 1991; 325:1738-1740
16. Landis CA, Masters SB, Spada A, et al. GTPase inhibiting mutations activate the a-chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature. 1989;340:692-696
17. Delaney D, Diss TC, Presneau N, et al. GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. Mod Pathol. 2009;22:718-724
18. Lee SE, Lee EH, Park H, et al. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: Meta-analysis of 168 sporadic cases. Hum Pathol. 2012;43:1234-1242
19. Yamada M, Sekine S, Ogawa R, et al. Frequent activating GNAS mutations in villous adenoma of the colorectum. J Pathol. 2012;228: 113-118
20. Nishikawa G, Sekine S, Ogawa R, et al. Frequent GNAS mutations in low-grade appendiceal mucinous neoplasm. Br J Cancer. 2013; 108:951-958
21. Lee SH, Jeong EG, Soung YH, et al. Absence of GNAS and EGFL6 mutations in common human cancers. Pathology. 2008;40:95-97
22. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010
23. Ban S, Naitoh Y, Mino-Kenudson M, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: Its histopathologic difference between 2 major types. Am J Surg Pathol. 2006;30: 1561-1569
24. Strazzabosco M, Fiorotto R, Melero S, et al. Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation. Hepatology. 2009;50:244-252
25. Banales JM, Prieto J, Medina JF. Cholangiocyte anion exchange and biliary bicarbonate excretion. World J Gastroenterol. 2006;12: 3496-3511
26. Masyuk AI, Masyuk TV, Splinter PL, et al. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology. 2006; 131:911-920
27. LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte proliferation. Liver. 2001;21:73-80
28. Boikos SA, Stratakis CA. Molecular genetics of the cAMPdependent protein kinase pathway and of sporadic pituitary tumorigenesis. Hum Mol Genet. 2007;16:80-87
29. Wilson CH, McIntyre RE, Arends MJ, et al. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene. 2010;29:4567-4575
30. Regard JB, Cherman N, Palmer D, et al. Wnt/beta-catenin signaling is differentially regulated by Galpha proteins and contributes to fibrous dysplasia. Proc Natl Acad Sci USA. 2011;108:20101-20106
31. Abraham SC, Lee JH, Hruban RH, et al. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol. 2003;34:902-910
32. Nakanuma Y, Zen Y, Harada K, et al. Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: An immunohistochemical approach. J Hepatobiliary Pancreat Sci. 2010;17:211-222
33. Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779-827
34. Matsubara A, Sekine S, Kushima R, et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol. 2013;229:579-587
35. Matthaei H, Wu J, Dal Molin M, et al. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB (Oxford). 2012;14:677-683